IDXX vs RGNX · P/E 40, rev $2.36B vs rev $114.4M
IDEXX Laboratories Inc (IDXX) versus Regenxbio Inc (RGNX) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Regenxbio Inc (RGNX) is a biotechnology company listed on US.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported RGNX revenue for 2026-06-30 was $114.4M. Net income was -$67.3M. RGNX currently screens at market cap $440.4M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. RGNX currently screens at market cap $440.4M.
Not investment advice. Open the IDXX and RGNX stock pages for the full models.
Not investment advice.